Under-identification of prenatal tobacco, nicotine and cannabis use and exposure in routine perinatal surveillance: findings from a prospective cohort of women expecting an Indigenous Australian baby
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background Routine perinatal data collection systems in Australia record maternal smoking during pregnancy but do not systematically capture many contemporary tobacco, nicotine and cannabis (TNC) products including e-cigarettes, nicotine replacement therapies and cannabis use. As patterns of antenatal risk exposure evolve, current perinatal datasets may underestimate prenatal TNC exposure. Methods This prospective observational study, co-designed with a local Indigenous health organisation, Indigenous leaders, and the local health service, was conducted in the Fraser Coast region of Queensland, Australia (2022–2024). Self-reported TNC use and exposure collected throughout pregnancy using a culturally safe ‘no shame, no blame’ approach among women expecting an Indigenous baby ( N = 83), were compared with matched Queensland Perinatal Data Collection (QPDC) records ( N = 80; excluding three pregnancies ending in miscarriage before 20 weeks’ gestation), to assess the extent to which routine perinatal surveillance may under-identify TNC use and exposure. Results Among 83 mothers expecting an Indigenous baby, self-report identified substantially higher TNC use and exposure than routine perinatal surveillance. Overall, 53 women (64%) reported using at least one TNC product during pregnancy, and 72 (87%) reported exposure to at least one product. Among the 80 participants with both NOTICE and QPDC data available, 41 (51%) were identified as cigaretter smokers through NOTICE compared with 34 (43% recroded as smokers in the QPDC. Cannabis use was reported by 22 women (27%); however, cannabis use could not be ascertained from QPDC records as illicit drug screening outcomes and substance-specific information are not collected. Conclusions Routine perinatal surveillance systems may underestimate prenatal TNC use and exposure, particularly for products not routinely captured within existing datasets. This may result in under-recognition of maternal and fetal exposure and may reduce opportunities for appropriate harm-minimisation support. Culturally safe, family-centred, non-judgmental assessment approaches may improve the disclosure and identification of contemporary TNC use and exposure during pregnancy.
Source: BMC Pregnancy and Childbirth
Institution: The University of Queensland
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,290
OpenAlex ID: W7225909673
